Brian C. Stephenson is CFO & Secretary +1 at BridgeBio Pharma, Inc. (BBIO). They have made 20 open-market trades across 2 companies since 2019, most recently 2026-07-01.
CIK 0001780030
5 open-market purchases totalling $2.6M since 2019, against 15 sales. Across 5 scored buys the stock is up 4.8% at ninety days, and 1.9 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| BBIO | 102,464 | $6.8M |
| FTH | 46,688 | $876K |
| Total | $7.7M |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 80% | 60% |
| Avg Move | +13.8% | +9.8% | +4.8% |
| Alpha | +13.2% | +10.0% | +1.9% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FTH | BUY | 2026-06-29 | 2026-07-01 | $23.92 | $326K | +49.9% | +15.8% | +18.9% |
| FTH | BUY | 2026-06-24 | 2026-06-26 | $25.65 | $401K | +30.0% | +25.5% | +24.1% |
| FTH | BUY | 2026-06-22 | 2026-06-24 | $23.31 | $406K | -1.9% | +3.5% | +24.5% |
| BBIO | SELL · 10b5-1 | 2025-02-25 | 2025-02-27 | $33.19 | $282K | -4.3% | +2.3% | -4.6% |
| BBIO | SELL · 10b5-1 | 2025-02-19 | 2025-02-19 | $36.16 | $300K | -16.2% | -11.8% | -14.4% |
| BBIO | SELL · 10b5-1 | 2025-01-28 | 2025-01-30 | $36.29 | $2.5M | -13.1% | -7.9% | +7.1% |
| BBIO | SELL · 10b5-1 | 2024-11-19 | 2024-11-20 | $22.41 | $186K | +15.4% | +15.0% | +54.0% |
| BBIO | SELL · 10b5-1 | 2024-08-19 | 2024-08-20 | $24.58 | $163K | +8.8% | +4.8% | -12.7% |
| BBIO | SELL · 10b5-1 | 2023-11-17 | 2023-11-20 | $29.10 | $1.3M | +8.0% | +33.3% | +25.4% |
| BBIO | SELL · 10b5-1 | 2023-08-17 | 2023-08-18 | $28.59 | $1.3M | +6.7% | +0.1% | +1.3% |
| BBIO | SELL · 10b5-1 | 2023-05-17 | 2023-05-18 | $14.01 | $684K | -3.2% | +16.6% | +110.3% |
| BBIO | SELL · 10b5-1 | 2023-05-03 | 2023-05-05 | $14.18 | $1.8M | -0.6% | +3.0% | +126.5% |
| BBIO | SELL · 10b5-1 | 2023-04-05 | 2023-04-07 | $15.45 | $857K | +8.7% | -11.9% | +10.8% |
| BBIO | SELL | 2023-03-03 | 2023-03-03 | $10.96 | $1.4M | -20.8% | -7.9% | -22.2% |
| BBIO | SELL | 2023-02-17 | 2023-02-21 | $12.68 | $422K | -9.5% | +13.1% | +14.2% |
| BBIO | SELL | 2023-02-03 | 2023-02-06 | $11.01 | $1.3M | +10.9% | +43.9% | +18.6% |
| BBIO | SELL | 2023-01-05 | 2023-01-06 | $7.67 | $936K | +8.5% | +52.3% | +107.9% |
| BBIO | SELL | 2022-11-17 | 2022-11-18 | $9.40 | $370K | -0.9% | -8.3% | +35.8% |
| BBIO | BUY | 2021-02-17 | 2021-02-18 | $62.50 | $500K | +0.6% | +5.1% | -16.4% |
| BBIO | SELL | 2020-08-03 | 2020-08-05 | $27.24 | $376K | +8.3% | +5.2% | +45.1% |
| BBIO | SELL | 2020-07-01 | 2020-07-06 | $30.93 | $334K | +4.5% | -5.6% | +35.5% |
| BBIO | SELL | 2020-06-08 | 2020-06-10 | $30.00 | $60K | +17.1% | +11.5% | +13.3% |
| BBIO | SELL · 10b5-1 | 2020-06-03 | 2020-06-05 | $30.04 | $48K | +6.6% | -0.3% | -5.0% |
| BBIO | SELL | 2020-06-01 | 2020-06-03 | $29.36 | $211K | +7.6% | +2.7% | -4.4% |
| BBIO | SELL | 2020-05-05 | 2020-05-06 | $30.49 | $348K | +6.3% | -11.2% | -16.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.